Stock Analysis on Net

Stryker Corp. (NYSE:SYK)

This company has been moved to the archive! The financial data has not been updated since April 29, 2022.

Economic Value Added (EVA)

Microsoft Excel

Economic Profit

Stryker Corp., economic profit calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net operating profit after taxes (NOPAT)1 2,015 1,867 2,347 2,098 1,187
Cost of capital2 12.30% 12.06% 12.29% 12.33% 12.37%
Invested capital3 26,516 27,132 23,274 20,767 17,502
 
Economic profit4 (1,247) (1,406) (512) (462) (978)

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 NOPAT. See details »

2 Cost of capital. See details »

3 Invested capital. See details »

4 2021 Calculation
Economic profit = NOPAT – Cost of capital × Invested capital
= 2,01512.30% × 26,516 = -1,247

Item Description The company
Economic profit Economic profit is a measure of corporate performance computed by taking the spread between the return on invested capital and the cost of capital, and multiplying by the invested capital. Stryker Corp. economic profit decreased from 2019 to 2020 but then slightly increased from 2020 to 2021.

Net Operating Profit after Taxes (NOPAT)

Stryker Corp., NOPAT calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net earnings 1,994 1,599 2,083 3,553 1,020
Deferred income tax expense (benefit)1 (237) 48 126 (1,582) 36
Increase (decrease) in allowance for doubtful accounts2 36 43 24 5 3
Increase (decrease) in equity equivalents3 (201) 91 150 (1,577) 39
Interest expense 337 315 287 264 247
Interest expense, operating lease liability4 12 11 13 10 10
Adjusted interest expense 349 326 300 274 257
Tax benefit of interest expense5 (73) (68) (63) (57) (90)
Adjusted interest expense, after taxes6 276 258 237 216 167
(Gain) loss on marketable securities (68) (102) (155) (119) (60)
Investment income, before taxes (68) (102) (155) (119) (60)
Tax expense (benefit) of investment income7 14 21 33 25 21
Investment income, after taxes8 (54) (81) (122) (94) (39)
Net operating profit after taxes (NOPAT) 2,015 1,867 2,347 2,098 1,187

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 Elimination of deferred tax expense. See details »

2 Addition of increase (decrease) in allowance for doubtful accounts.

3 Addition of increase (decrease) in equity equivalents to net earnings.

4 2021 Calculation
Interest expense on capitalized operating leases = Operating lease liability × Discount rate
= 422 × 2.86% = 12

5 2021 Calculation
Tax benefit of interest expense = Adjusted interest expense × Statutory income tax rate
= 349 × 21.00% = 73

6 Addition of after taxes interest expense to net earnings.

7 2021 Calculation
Tax expense (benefit) of investment income = Investment income, before tax × Statutory income tax rate
= 68 × 21.00% = 14

8 Elimination of after taxes investment income.

Item Description The company
NOPAT Net operating profit after taxes is income from operations, but after removement of taxes calculated on cash basis that are relevant to operating income. Stryker Corp. NOPAT decreased from 2019 to 2020 but then slightly increased from 2020 to 2021.

Cash Operating Taxes

Stryker Corp., cash operating taxes calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Income tax expense (benefit) 287 355 479 (1,197) 1,043
Less: Deferred income tax expense (benefit) (237) 48 126 (1,582) 36
Add: Tax savings from interest expense 73 68 63 57 90
Less: Tax imposed on investment income 14 21 33 25 21
Cash operating taxes 583 354 383 417 1,076

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Item Description The company
Cash operating taxes Cash operating taxes are estimated by adjusting income tax expense for changes in deferred taxes and tax benefit from the interest deduction. Stryker Corp. cash operating taxes decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.

Invested Capital

Stryker Corp., invested capital calculation (financing approach)

US$ in millions

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Current maturities of debt 7 761 859 1,373 632
Long-term debt, excluding current maturities 12,472 13,230 10,231 8,486 6,590
Operating lease liability1 422 434 387 308 296
Total reported debt & leases 12,901 14,425 11,477 10,167 7,518
Total Stryker shareholders’ equity 14,877 13,084 12,807 11,730 9,966
Net deferred tax (assets) liabilities2 (1,692) (1,413) (1,467) (1,624) (236)
Allowance for doubtful accounts3 167 131 88 64 59
Equity equivalents4 (1,525) (1,282) (1,379) (1,560) (177)
Accumulated other comprehensive (income) loss, net of tax5 531 1,157 606 631 553
Non-controlling interest 14
Adjusted total Stryker shareholders’ equity 13,883 12,959 12,034 10,801 10,356
Marketable securities6 (268) (252) (237) (201) (372)
Invested capital 26,516 27,132 23,274 20,767 17,502

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 Addition of capitalized operating leases.

2 Elimination of deferred taxes from assets and liabilities. See details »

3 Addition of allowance for doubtful accounts receivable.

4 Addition of equity equivalents to total Stryker shareholders’ equity.

5 Removal of accumulated other comprehensive income.

6 Subtraction of marketable securities.

Item Description The company
Invested capital Capital is an approximation of the economic book value of all cash invested in going-concern business activities. Stryker Corp. invested capital increased from 2019 to 2020 but then slightly decreased from 2020 to 2021.

Cost of Capital

Stryker Corp., cost of capital calculations

Capital (fair value)1 Weights Cost of capital
Equity2 95,009 95,009 ÷ 108,832 = 0.87 0.87 × 13.82% = 12.07%
Debt3 13,401 13,401 ÷ 108,832 = 0.12 0.12 × 2.33% × (1 – 21.00%) = 0.23%
Operating lease liability4 422 422 ÷ 108,832 = 0.00 0.00 × 2.86% × (1 – 21.00%) = 0.01%
Total: 108,832 1.00 12.30%

Based on: 10-K (reporting date: 2021-12-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 92,297 92,297 ÷ 108,169 = 0.85 0.85 × 13.82% = 11.79%
Debt3 15,438 15,438 ÷ 108,169 = 0.14 0.14 × 2.32% × (1 – 21.00%) = 0.26%
Operating lease liability4 434 434 ÷ 108,169 = 0.00 0.00 × 2.57% × (1 – 21.00%) = 0.01%
Total: 108,169 1.00 12.06%

Based on: 10-K (reporting date: 2020-12-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 81,747 81,747 ÷ 94,070 = 0.87 0.87 × 13.82% = 12.01%
Debt3 11,936 11,936 ÷ 94,070 = 0.13 0.13 × 2.63% × (1 – 21.00%) = 0.26%
Operating lease liability4 387 387 ÷ 94,070 = 0.00 0.00 × 3.34% × (1 – 21.00%) = 0.01%
Total: 94,070 1.00 12.29%

Based on: 10-K (reporting date: 2019-12-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 67,359 67,359 ÷ 77,539 = 0.87 0.87 × 13.82% = 12.01%
Debt3 9,872 9,872 ÷ 77,539 = 0.13 0.13 × 3.09% × (1 – 21.00%) = 0.31%
Operating lease liability4 308 308 ÷ 77,539 = 0.00 0.00 × 3.09% × (1 – 21.00%) = 0.01%
Total: 77,539 1.00 12.33%

Based on: 10-K (reporting date: 2018-12-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 55,451 55,451 ÷ 63,303 = 0.88 0.88 × 13.82% = 12.11%
Debt3 7,556 7,556 ÷ 63,303 = 0.12 0.12 × 3.22% × (1 – 35.00%) = 0.25%
Operating lease liability4 296 296 ÷ 63,303 = 0.00 0.00 × 3.22% × (1 – 35.00%) = 0.01%
Total: 63,303 1.00 12.37%

Based on: 10-K (reporting date: 2017-12-31).

1 US$ in millions

2 Equity. See details »

3 Debt. See details »

4 Operating lease liability. See details »


Economic Spread Ratio

Stryker Corp., economic spread ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Economic profit1 (1,247) (1,406) (512) (462) (978)
Invested capital2 26,516 27,132 23,274 20,767 17,502
Performance Ratio
Economic spread ratio3 -4.70% -5.18% -2.20% -2.22% -5.59%
Benchmarks
Economic Spread Ratio, Competitors4
Abbott Laboratories 0.66% -2.61% -3.93%
Cigna Group -0.21% 2.68% -0.53%
CVS Health Corp. -0.03% 0.42% -0.36%
Elevance Health Inc. 1.08% -0.90% -0.07%
Humana Inc. 2.69% 9.55% 7.68%
Intuitive Surgical Inc. 20.60% 8.59% 25.27%
Medtronic PLC -4.49% -3.60% -2.52%
UnitedHealth Group Inc. 4.57% 5.14% 5.17%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 Economic profit. See details »

2 Invested capital. See details »

3 2021 Calculation
Economic spread ratio = 100 × Economic profit ÷ Invested capital
= 100 × -1,247 ÷ 26,516 = -4.70%

4 Click competitor name to see calculations.

Performance ratio Description The company
Economic spread ratio The ratio of economic profit to invested capital, also equal to the difference between return on invested capital (ROIC) and cost of capital. Stryker Corp. economic spread ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021.

Economic Profit Margin

Stryker Corp., economic profit margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Economic profit1 (1,247) (1,406) (512) (462) (978)
Net sales 17,108 14,351 14,884 13,601 12,444
Performance Ratio
Economic profit margin2 -7.29% -9.80% -3.44% -3.40% -7.86%
Benchmarks
Economic Profit Margin, Competitors3
Abbott Laboratories 0.95% -4.55% -7.16%
Cigna Group -0.11% 1.58% -0.32%
CVS Health Corp. -0.01% 0.21% -0.20%
Elevance Health Inc. 0.50% -0.43% -0.04%
Humana Inc. 0.99% 2.74% 2.25%
Intuitive Surgical Inc. 16.21% 8.81% 18.73%
Medtronic PLC -10.76% -8.87% -5.98%
UnitedHealth Group Inc. 2.24% 2.62% 2.52%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 Economic profit. See details »

2 2021 Calculation
Economic profit margin = 100 × Economic profit ÷ Net sales
= 100 × -1,247 ÷ 17,108 = -7.29%

3 Click competitor name to see calculations.

Performance ratio Description The company
Economic profit margin The ratio of economic profit to sales. It is the company profit margin covering income efficiency and asset management. Economic profit margin is not biased in favor of capital-intensive business models, because any added capital is a cost to the economic profit margin. Stryker Corp. economic profit margin deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021.